Evolution of ramucirumab in the treatment of cancer - A review of literature
about
Gastric cancer management: Kinases as a target therapy.Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2.Remodeling of the Extracellular Matrix by Endothelial Cell-Targeting siRNA Improves the EPR-Based Delivery of 100 nm Particles.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Eruptive cherry angiomas developing in a patient treated with ramucirumab.
P2860
Evolution of ramucirumab in the treatment of cancer - A review of literature
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Evolution of ramucirumab in the treatment of cancer - A review of literature
@ast
Evolution of ramucirumab in the treatment of cancer - A review of literature
@en
Evolution of ramucirumab in the treatment of cancer - A review of literature
@nl
type
label
Evolution of ramucirumab in the treatment of cancer - A review of literature
@ast
Evolution of ramucirumab in the treatment of cancer - A review of literature
@en
Evolution of ramucirumab in the treatment of cancer - A review of literature
@nl
prefLabel
Evolution of ramucirumab in the treatment of cancer - A review of literature
@ast
Evolution of ramucirumab in the treatment of cancer - A review of literature
@en
Evolution of ramucirumab in the treatment of cancer - A review of literature
@nl
P2093
P2860
P356
P1476
Evolution of ramucirumab in the treatment of cancer - A review of literature
@en
P2093
A Vennepureddy
J P Atallah
T Terjanian
P2860
P356
10.1177/1078155216655474
P407
P577
2016-06-15T00:00:00Z